{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:52:22Z","timestamp":1648749142444},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.disamonth.2011.02.006","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T19:37:53Z","timestamp":1301341073000},"page":"135-141","source":"Crossref","is-referenced-by-count":0,"title":["Medical Treatment of Tremor"],"prefix":"10.1016","volume":"57","author":[{"given":"Arif","family":"Dalvi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2011.02.006_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"64","author":"Zesiewicz","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib2","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJM197405022901802","article-title":"Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties","volume":"290","author":"Winkler","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.disamonth.2011.02.006_bib3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.25.11.1041","article-title":"Essential tremor: treatment with propranolol","volume":"25","author":"Tolosa","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/jnnp.46.5.393","article-title":"The response of essential tremor to propranolol: evaluation of clinical variables governing its efficacy on prolonged administration","volume":"46","author":"Calzetti","year":"1983","journal-title":"J Neurol Neurosurg, Psychiatry"},{"key":"10.1016\/j.disamonth.2011.02.006_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archneur.1986.00520010038018","article-title":"Dose\u2013response relationship of propranolol in the treatment of essential tremor","volume":"43","author":"Koller","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/j.disamonth.2011.02.006_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.35.1.108","article-title":"Long-acting propranolol in essential tremor","volume":"35","author":"Koller","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib7","article-title":"Essential tremor","author":"Ferreira","year":"2007","journal-title":"Clin Evid (Online)"},{"key":"10.1016\/j.disamonth.2011.02.006_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.36.1.121","article-title":"Efficacy of primidone in essential tremor","volume":"36","author":"Koller","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1353-8020(03)00070-1","article-title":"Use of primidone in low doses (250 mg\/day) versus high doses (750 mg\/day) in the management of essential tremor","volume":"10","author":"Serrano-Due\u00f1as","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.disamonth.2011.02.006_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1212\/WNL.38.5.808","article-title":"Double-blind comparison of primidone and phenobarbital in essential tremor","volume":"38","author":"Sasso","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00002018-200326070-00003","article-title":"Benefits and risks of pharmacological treatments for essential tremor","volume":"26","author":"Lyons","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.disamonth.2011.02.006_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archneur.56.4.475","article-title":"A randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremor","volume":"56","author":"Gironell","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.disamonth.2011.02.006_bib13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0","article-title":"Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial","volume":"15","author":"Ondo","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.disamonth.2011.02.006_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mds.870130315","article-title":"Double-blind controlled trial of gabapentin in essential tremor","volume":"13","author":"Pahwa","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.disamonth.2011.02.006_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/WNF.0b013e3180d09969","article-title":"Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials","volume":"31","author":"Connor","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.disamonth.2011.02.006_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: a double-blind, placebo-controlled trial","volume":"66","author":"Ondo","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/WNL.38.2.241","article-title":"Efficacy of alprazolam for essential tremor","volume":"38","author":"Huber","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.45.4.822","article-title":"Botulinum toxin treatment of essential head tremor","volume":"45","author":"Pahwa","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.disamonth.2011.02.006_bib20","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1176\/ajp.139.11.1471","article-title":"High alcoholism rate in patients with essential tremor","volume":"139","author":"Schroeder","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.disamonth.2011.02.006_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1212\/01.WNL.0000101722.95137.19","article-title":"Pilot trial of 1-octanol in essential tremor","volume":"62","author":"Bushara","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib22","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1212\/01.wnl.0000188670.38576.bd","article-title":"A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor","volume":"65","author":"Frucht","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib23","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1586\/ern.09.117","article-title":"Current strategies in the treatment of Parkinson's disease and a personalized approach to management","volume":"9","author":"Diaz","year":"2009","journal-title":"Exp Rev Neurother"},{"key":"10.1016\/j.disamonth.2011.02.006_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archneur.1987.00520210023013","article-title":"Adjuvant therapy of parkinsonian tremor","volume":"44","author":"Koller","year":"1987","journal-title":"Arch Neurol"},{"key":"10.1016\/j.disamonth.2011.02.006_bib25","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.48.4.1077","article-title":"Benztropine versus clozapine for the treatment of tremor in Parkinson's disease","volume":"48","author":"Friedman","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.disamonth.2011.02.006_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1353-8020(02)00011-1","article-title":"Mirtazapine in Parkinsonian tremor","volume":"9","author":"Gordon","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.disamonth.2011.02.006_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00415-006-0296-7","article-title":"Tremor in multiple sclerosis","volume":"254","author":"Koch","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.disamonth.2011.02.006_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/WNF.0b013e3181f84a39","article-title":"Successful treatment of cerebellar ataxia and tremor in multiple sclerosis with topiramate: a case report","volume":"33","author":"Schroeder","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.disamonth.2011.02.006_bib29","first-page":"900","article-title":"Dystonic tremor","volume":"159","author":"Deuschl","year":"2003","journal-title":"Rev Neurol Paris"},{"key":"10.1016\/j.disamonth.2011.02.006_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2007-971171","article-title":"Botulinum toxin in movement disorders","volume":"27","author":"Papapetropoulos","year":"2007","journal-title":"Semin Neurol"},{"key":"10.1016\/j.disamonth.2011.02.006_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.parkreldis.2010.06.013","article-title":"Advances in primary writing tremor","volume":"16","author":"Hai","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.disamonth.2011.02.006_bib32","series-title":"Handbook of Essential Tremor and Other Tremor Disorders","first-page":"243","article-title":"Holmes tremor","author":"Dalvi","year":"2005"},{"key":"10.1016\/j.disamonth.2011.02.006_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ageing\/afp008","article-title":"Shaky legs?","volume":"38","author":"Ramtahal","year":"2009","journal-title":"Think POT! Age Ageing"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502911000496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502911000496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T21:51:06Z","timestamp":1543873866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502911000496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0011502911000496"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2011.02.006","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}